Or if you're already a Pharma IQ member, sign in below to download. Sign In Join
Mandar Kodgule, Head of Intellectual Property and Strategic Planning at Wockhardt, answers this question as well as offering the top five strategic considerations to sustain a healthy polymorph patent portfolio and to create polymorphic wealth. In this interview with Helen Winsor from Pharma IQ, he also touches upon how the regulatory landscape is changing and what impact it is having on enforceability of polymorph patents. Kodgule also addresses the issue of excessive innovation in the polymorph arena, which is leading to misuse in certain cases, and why this is so. Haven’t got the technology to listen to the podcast? Read the interview here Best Practice Ways to Develop IP Strategies for Crystalline Forms.